124 related articles for article (PubMed ID: 18194419)
1. Fluoxetine (Prozac) augments platelet activation mediated through protease-activated receptors.
Dilks JR; Flaumenhaft R
J Thromb Haemost; 2008 Apr; 6(4):705-8. PubMed ID: 18194419
[No Abstract] [Full Text] [Related]
2. Potentiation of TRAP-6-induced platelet dense granule release by blockade of P2Y
Mitrugno A; Rigg RA; Laschober NB; Ngo ATP; Pang J; Williams CD; Aslan JE; McCarty OJT
Platelets; 2018 Jun; 29(4):383-394. PubMed ID: 28523947
[TBL] [Abstract][Full Text] [Related]
3. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor-induced Akt activation--regulation and possible function.
Reséndiz JC; Kroll MH; Lassila R
J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
[TBL] [Abstract][Full Text] [Related]
6. Residual platelet activation through protease-activated receptors (PAR)-1 and -4 in patients on P2Y12 inhibitors.
Badr Eslam R; Lang IM; Koppensteiner R; Calatzis A; Panzer S; Gremmel T
Int J Cardiol; 2013 Sep; 168(1):403-6. PubMed ID: 23041015
[TBL] [Abstract][Full Text] [Related]
7. Specific activation, signalling and secretion profiles of human platelets following PAR-1 and PAR-4 stimulation.
Nguyen KA; Hamzeh-Cognasse H; Laradi S; Pozzetto B; Garraud O; Cognasse F
Platelets; 2015; 26(8):795-8. PubMed ID: 26083907
[TBL] [Abstract][Full Text] [Related]
8. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
[TBL] [Abstract][Full Text] [Related]
9. P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation.
Shankar H; Garcia A; Prabhakar J; Kim S; Kunapuli SP
J Thromb Haemost; 2006 Mar; 4(3):638-47. PubMed ID: 16460446
[TBL] [Abstract][Full Text] [Related]
10. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
11. Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin.
Lova P; Campus F; Lombardi R; Cattaneo M; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2004 Jun; 279(24):25299-306. PubMed ID: 15078882
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.
Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC
Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
Etulain J; Mena HA; Negrotto S; Schattner M
Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
[TBL] [Abstract][Full Text] [Related]
15. Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin.
Ofosu FA; Dewar L; Craven SJ; Song Y; Cedrone A; Freedman J; Fenton JW
J Biol Chem; 2008 Oct; 283(40):26886-93. PubMed ID: 18682394
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a new peptide agonist of the protease-activated receptor-1.
Mao Y; Jin J; Kunapuli SP
Biochem Pharmacol; 2008 Jan; 75(2):438-47. PubMed ID: 17950254
[TBL] [Abstract][Full Text] [Related]
17. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of an action pathway in mouse platelets leading to prolongation of bleeding time by fluoxetine.
Li R; Qu J; Wu C; Fang Z; Hong X; Xu H
Eur J Pharmacol; 2020 Sep; 883():173385. PubMed ID: 32710955
[TBL] [Abstract][Full Text] [Related]
19. Enhanced platelet aggregation and activation under conditions of hypothermia.
Xavier RG; White AE; Fox SC; Wilcox RG; Heptinstall S
Thromb Haemost; 2007 Dec; 98(6):1266-75. PubMed ID: 18064324
[TBL] [Abstract][Full Text] [Related]
20. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.
Badr Eslam R; Lang IM; Kaider A; Panzer S
Transl Res; 2013 May; 161(5):414-20. PubMed ID: 23313628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]